TRPC6 enhances angiotensin II-induced albuminuria

Jason Eckel, Peter J. Lavin, Elizabeth A. Finch, Nirvan Mukerji, Jarrett Burch, Rasheed Gbadegesin, Guanghong Wu, Brandy Bowling, Alison Byrd, Gentzon Hall, Matthew Sparks, Zhu Shan Zhang, Alison Homstad, Laura Barisoni-Thomas, Lutz Birbaumer, Paul Rosenberg, Michelle P. Winn

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Mutations in the canonical transient receptor potential cation channel 6 (TRPC6) are responsible for familial forms of adult onset focal segmental glomerulosclerosis (FSGS). The mechanisms by which TRPC6 mutations cause kidney disease are not well understood. We used TRPC6-deficient mice to examine the function of TRPC6 in the kidney. We found that adult TRPC6-deficient mice had BP and albumin excretion rates similar to wild-type animals. Glomerular histomorphology revealed no abnormalities on both light and electron microscopy. To determine whether the absence of TRPC6 would alter susceptibility to hypertension and renal injury, we infused mice with angiotensin II continuously for 28 days. Although both groups developed similar levels of hypertension, TRPC6-deficient mice had significantly less albuminuria, especially during the early phase of the infusion; this suggested that TRPC6 adversely influences the glomerular filter. We used whole-cell patch-clamp recording to measure cellmembrane currents in primary cultures of podocytes from both wild-type and TRPC6-deficient mice. In podocytes from wild-type mice, angiotensin II and a direct activator of TRPC6 both augmented cell-membrane currents; TRPC6 deficiency abrogated these increases in current magnitude. Our findings suggest that TRPC6 promotes albuminuria, perhaps by promoting angiotensin II-dependent increases in Ca2+, suggesting that TRPC6 blockade may be therapeutically beneficial in proteinuric kidney disease.

Original languageEnglish
Pages (from-to)526-535
Number of pages10
JournalJournal of the American Society of Nephrology
Volume22
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Transient Receptor Potential Channels
Albuminuria
Angiotensin II
Podocytes
Kidney Diseases
Focal Segmental Glomerulosclerosis
Mutation
Renal Hypertension
Wild Animals

ASJC Scopus subject areas

  • Nephrology

Cite this

Eckel, J., Lavin, P. J., Finch, E. A., Mukerji, N., Burch, J., Gbadegesin, R., ... Winn, M. P. (2011). TRPC6 enhances angiotensin II-induced albuminuria. Journal of the American Society of Nephrology, 22(3), 526-535. https://doi.org/10.1681/ASN.2010050522

TRPC6 enhances angiotensin II-induced albuminuria. / Eckel, Jason; Lavin, Peter J.; Finch, Elizabeth A.; Mukerji, Nirvan; Burch, Jarrett; Gbadegesin, Rasheed; Wu, Guanghong; Bowling, Brandy; Byrd, Alison; Hall, Gentzon; Sparks, Matthew; Zhang, Zhu Shan; Homstad, Alison; Barisoni-Thomas, Laura; Birbaumer, Lutz; Rosenberg, Paul; Winn, Michelle P.

In: Journal of the American Society of Nephrology, Vol. 22, No. 3, 01.03.2011, p. 526-535.

Research output: Contribution to journalArticle

Eckel, J, Lavin, PJ, Finch, EA, Mukerji, N, Burch, J, Gbadegesin, R, Wu, G, Bowling, B, Byrd, A, Hall, G, Sparks, M, Zhang, ZS, Homstad, A, Barisoni-Thomas, L, Birbaumer, L, Rosenberg, P & Winn, MP 2011, 'TRPC6 enhances angiotensin II-induced albuminuria', Journal of the American Society of Nephrology, vol. 22, no. 3, pp. 526-535. https://doi.org/10.1681/ASN.2010050522
Eckel J, Lavin PJ, Finch EA, Mukerji N, Burch J, Gbadegesin R et al. TRPC6 enhances angiotensin II-induced albuminuria. Journal of the American Society of Nephrology. 2011 Mar 1;22(3):526-535. https://doi.org/10.1681/ASN.2010050522
Eckel, Jason ; Lavin, Peter J. ; Finch, Elizabeth A. ; Mukerji, Nirvan ; Burch, Jarrett ; Gbadegesin, Rasheed ; Wu, Guanghong ; Bowling, Brandy ; Byrd, Alison ; Hall, Gentzon ; Sparks, Matthew ; Zhang, Zhu Shan ; Homstad, Alison ; Barisoni-Thomas, Laura ; Birbaumer, Lutz ; Rosenberg, Paul ; Winn, Michelle P. / TRPC6 enhances angiotensin II-induced albuminuria. In: Journal of the American Society of Nephrology. 2011 ; Vol. 22, No. 3. pp. 526-535.
@article{14b8601cba5c406d8d4f913b416c3218,
title = "TRPC6 enhances angiotensin II-induced albuminuria",
abstract = "Mutations in the canonical transient receptor potential cation channel 6 (TRPC6) are responsible for familial forms of adult onset focal segmental glomerulosclerosis (FSGS). The mechanisms by which TRPC6 mutations cause kidney disease are not well understood. We used TRPC6-deficient mice to examine the function of TRPC6 in the kidney. We found that adult TRPC6-deficient mice had BP and albumin excretion rates similar to wild-type animals. Glomerular histomorphology revealed no abnormalities on both light and electron microscopy. To determine whether the absence of TRPC6 would alter susceptibility to hypertension and renal injury, we infused mice with angiotensin II continuously for 28 days. Although both groups developed similar levels of hypertension, TRPC6-deficient mice had significantly less albuminuria, especially during the early phase of the infusion; this suggested that TRPC6 adversely influences the glomerular filter. We used whole-cell patch-clamp recording to measure cellmembrane currents in primary cultures of podocytes from both wild-type and TRPC6-deficient mice. In podocytes from wild-type mice, angiotensin II and a direct activator of TRPC6 both augmented cell-membrane currents; TRPC6 deficiency abrogated these increases in current magnitude. Our findings suggest that TRPC6 promotes albuminuria, perhaps by promoting angiotensin II-dependent increases in Ca2+, suggesting that TRPC6 blockade may be therapeutically beneficial in proteinuric kidney disease.",
author = "Jason Eckel and Lavin, {Peter J.} and Finch, {Elizabeth A.} and Nirvan Mukerji and Jarrett Burch and Rasheed Gbadegesin and Guanghong Wu and Brandy Bowling and Alison Byrd and Gentzon Hall and Matthew Sparks and Zhang, {Zhu Shan} and Alison Homstad and Laura Barisoni-Thomas and Lutz Birbaumer and Paul Rosenberg and Winn, {Michelle P.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1681/ASN.2010050522",
language = "English",
volume = "22",
pages = "526--535",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "3",

}

TY - JOUR

T1 - TRPC6 enhances angiotensin II-induced albuminuria

AU - Eckel, Jason

AU - Lavin, Peter J.

AU - Finch, Elizabeth A.

AU - Mukerji, Nirvan

AU - Burch, Jarrett

AU - Gbadegesin, Rasheed

AU - Wu, Guanghong

AU - Bowling, Brandy

AU - Byrd, Alison

AU - Hall, Gentzon

AU - Sparks, Matthew

AU - Zhang, Zhu Shan

AU - Homstad, Alison

AU - Barisoni-Thomas, Laura

AU - Birbaumer, Lutz

AU - Rosenberg, Paul

AU - Winn, Michelle P.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Mutations in the canonical transient receptor potential cation channel 6 (TRPC6) are responsible for familial forms of adult onset focal segmental glomerulosclerosis (FSGS). The mechanisms by which TRPC6 mutations cause kidney disease are not well understood. We used TRPC6-deficient mice to examine the function of TRPC6 in the kidney. We found that adult TRPC6-deficient mice had BP and albumin excretion rates similar to wild-type animals. Glomerular histomorphology revealed no abnormalities on both light and electron microscopy. To determine whether the absence of TRPC6 would alter susceptibility to hypertension and renal injury, we infused mice with angiotensin II continuously for 28 days. Although both groups developed similar levels of hypertension, TRPC6-deficient mice had significantly less albuminuria, especially during the early phase of the infusion; this suggested that TRPC6 adversely influences the glomerular filter. We used whole-cell patch-clamp recording to measure cellmembrane currents in primary cultures of podocytes from both wild-type and TRPC6-deficient mice. In podocytes from wild-type mice, angiotensin II and a direct activator of TRPC6 both augmented cell-membrane currents; TRPC6 deficiency abrogated these increases in current magnitude. Our findings suggest that TRPC6 promotes albuminuria, perhaps by promoting angiotensin II-dependent increases in Ca2+, suggesting that TRPC6 blockade may be therapeutically beneficial in proteinuric kidney disease.

AB - Mutations in the canonical transient receptor potential cation channel 6 (TRPC6) are responsible for familial forms of adult onset focal segmental glomerulosclerosis (FSGS). The mechanisms by which TRPC6 mutations cause kidney disease are not well understood. We used TRPC6-deficient mice to examine the function of TRPC6 in the kidney. We found that adult TRPC6-deficient mice had BP and albumin excretion rates similar to wild-type animals. Glomerular histomorphology revealed no abnormalities on both light and electron microscopy. To determine whether the absence of TRPC6 would alter susceptibility to hypertension and renal injury, we infused mice with angiotensin II continuously for 28 days. Although both groups developed similar levels of hypertension, TRPC6-deficient mice had significantly less albuminuria, especially during the early phase of the infusion; this suggested that TRPC6 adversely influences the glomerular filter. We used whole-cell patch-clamp recording to measure cellmembrane currents in primary cultures of podocytes from both wild-type and TRPC6-deficient mice. In podocytes from wild-type mice, angiotensin II and a direct activator of TRPC6 both augmented cell-membrane currents; TRPC6 deficiency abrogated these increases in current magnitude. Our findings suggest that TRPC6 promotes albuminuria, perhaps by promoting angiotensin II-dependent increases in Ca2+, suggesting that TRPC6 blockade may be therapeutically beneficial in proteinuric kidney disease.

UR - http://www.scopus.com/inward/record.url?scp=79952344547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952344547&partnerID=8YFLogxK

U2 - 10.1681/ASN.2010050522

DO - 10.1681/ASN.2010050522

M3 - Article

C2 - 21258036

AN - SCOPUS:79952344547

VL - 22

SP - 526

EP - 535

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 3

ER -